Category Specific RSS

Samantha Freidin

Latitude IPO successful but how big will the exit selldown be?

The saying ‘third time’s a charm’ rings true for financial services company Latitude (ASX: LFS) who finally made their entrance…

5 years ago

PharmAust is putting a leash on canine cancer, and COVID-19

From high rise city apartments to the rolling hills of the countryside, you’re likely to find a dog or two…

5 years ago

How 4DMedical is changing the medtech game post COVID

While we are seemingly on the back-stretch of the COVID-19 pandemic, increased medical awareness has changed how we diagnose respiratory…

5 years ago

High-touch, high-quality maternity care could soon become standard in major hospitals

Bringing telehealth to expectant mothers that will rival major hospital facilities, medtech company HeraMED (ASX: HMD) is taking a significant…

5 years ago

New Anatara trial to tackle anxiety, stress and depression with diet supplement

Working in conjunction with the CSIRO, Anatara Lifesciences (ASX: ANR) has received ethics approval to apply their diet supplement 3FDC…

5 years ago

Could Creso’s psychedelics solve Australia’s $10.6 billion problem?

According to the Australian Department of Health, half of us will experience some form of mental illness in our lifetime.…

5 years ago